Blood pressure medication alternatives during pregnancy

How do the options compare?

Options are compared on ACOG or MotherToBaby endorsement, size and quality of pregnancy-specific studies, dosing predictability, time-to-effect, and side-effect profile: the same axes an obstetric clinician would use.

• Pregnancy hypertension guidance lists labetalol first, nifedipine when labetalol is unsuitable, and methyldopa when the first two are unsuitable, with choice based on side effects, fetal effects, risk, and patient preferences. 1
• A systematic pharmacokinetic review identifies methyldopa, labetalol, and nifedipine as commonly recommended pregnancy medicines, while noting important gaps in dosing and outcome evidence. 2
• A scientific statement says there is no clear evidence that one pregnancy antihypertensive is preferable across all pregnancy hypertension groups, although labetalol, methyldopa, and nifedipine are accepted options in different guidance. 3
• A recent pharmacotherapy review describes beta-blockers, calcium-channel blockers, and methyldopa as the main medication classes used in pregnancy and notes that a head-to-head labetalol versus nifedipine trial was still recruiting. 4
• A pharmacological guideline lists methyldopa, labetalol, and nifedipine among preferred pregnancy medicines and identifies ACE inhibitors and ARBs as agents with direct fetal concerns. 5

Which option makes sense?

A comparison can include options that should be avoided or considered only in specific circumstances. Please consult your healthcare provider about the findings and cautions that apply to you.

Disclosure: Pregnancy Smart makes pregnancy supplements, though not in this category. This comparison is a plain description of the pregnancy evidence, not a sales page.